Richard A. Larson

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801”.

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Blood Advances(2020)10.1182/bloodadvances.2019000492

N/A

2.8DataRank · unranked

72 citations

Susan M. Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Geoffrey L. Uy +12 more

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

Leukemia(2023)10.1038/s41375-023-02068-8

N/A

1.8DataRank · unranked

39 citations

Deedra Nicolet, Krzysztof Mrózek, Ayse S. Yilmaz, Jessica Kohlschmidt, Karilyn Larkin +35 more

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Blood Advances(2020)10.1182/bloodadvances.2020002904

N/A

1.5DataRank · unranked

61 citations

Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101

Blood Advances(2022)10.1182/bloodadvances.2021006872

N/A

1.1DataRank · unranked

40 citations

Heidi D. Klepin, Elizabeth Storrick, Brittny Major, Jennifer Le‐Rademacher, Martha Wadleigh +4 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Blood Advances(2023)10.1182/bloodadvances.2022009325

N/A

0.524DataRank · unranked

9 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly +15 more

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia(2025)10.1038/s41375-025-02644-0

N/A

0.165DataRank · unranked

2 citations

Karilyn Larkin, Deedra Nicolet, Vindi Jurinović, Krzysztof Mrózek, Aarif M.N. Batcha +30 more

White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years

American Journal of Hematology(2024)10.1002/ajh.27465

N/A

0.124DataRank · unranked

1 citations

Deedra Nicolet, Krzysztof Mrózek, Christopher J. Walker, James S. Blachly, Jessica Kohlschmidt +10 more

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Leukemia(2021)10.1038/s41375-021-01323-0

N/A

0DataRank · unranked

90 citations

Ling Du, Tamara J. Luck, Axel Benner, Julia Krzykalla, Insa Gathmann +25 more

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Leukemia(2021)10.1038/s41375-021-01213-5

N/A

0DataRank · unranked

42 citations

Wendy Stock, Anjali S. Advani, Selina M. Luger, Richard A. Larson, Martin S. Tallman +22 more

Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial

Leukemia Research(2021)10.1016/j.leukres.2021.106736

N/A

0DataRank · unranked

6 citations

Victoria X. Wang, Jacob M. Rowe, Mark R. Litzow, Elisabeth Paietta, Rhett P. Ketterling +11 more

Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10520

N/A

0DataRank · unranked

1 citations

Lingyun Ji, Xinxin Xu, Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas +10 more

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

Leukemia(2022)10.1038/s41375-022-01650-w

N/A

0DataRank · unranked

39 citations

Maral Saadati, Lars Bullinger, Richard A. Larson, Tiziana Ottone, Sergio Amadori +18 more

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML

Blood Advances(2022)10.1182/bloodadvances.2022007544

N/A

0DataRank · unranked

35 citations

Deedra Nicolet, Benjamin Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller +25 more

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

British Journal of Haematology(2022)10.1111/bjh.18543

N/A

0DataRank · unranked

3 citations

Tomi Jun, Andrew D. Skol, Riyue Bao, Lei Huang, Sapana Vora +12 more

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

JCO Oncology Practice(2020)10.1200/jop.19.00133

N/A

0DataRank · unranked

23 citations

Megan Othus, Guillermo Garcia‐Manero, Min Fang, Jerald P. Radich, David A. Rizzieri +24 more

Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-23-0106

N/A

0DataRank · unranked

33 citations

Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S. Sperling, Lachelle D. Weeks +30 more

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Leukemia(2024)10.1038/s41375-024-02143-8

N/A

0DataRank · unranked

6 citations

Andrew H. Wei, Sumithra J. Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse‐Chieh Teh +24 more

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation

Haematologica(2024)10.3324/haematol.2023.284584

N/A

0DataRank · unranked

2 citations

Satyajit Kosuri, Mariam T. Nawas, Adam DuVall, Anand Patel, Peter A. Riedell +12 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

UNC Libraries(2020)10.17615/h6kv-p452

N/A

0DataRank · unranked

0 citations

François Guilhot, Martin Müller, Jiřı́ Mayer, Richard A. Larson, Susanne Saußele +14 more

Hematologic complications in patients exposed to PARP inhibitors

medRxiv(2025)10.1101/2025.07.01.25329998

N/A

0DataRank · unranked

0 citations

Muriel R. Battaglia, Gregory W. Roloff, Sinan Çetin, Michael Tallarico, W Stock +9 more

Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20004

N/A

0DataRank · unranked

0 citations

Sumithra J. Mandrekar, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander +15 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17

N/A

0DataRank · unranked

0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

UNC Libraries(2020)10.17615/q2fj-2t55

N/A

0DataRank · unranked

0 citations

Flora Mulkey, Robert Z. Orlowski, Ben L. Sanford, Richard A. Larson, Susan M. Geyer +5 more